An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects

被引：0
|
作者：
Desmond Padhi
Craig B. Langman
Sahar Fathallah-Shaykh
Bradley A. Warady
Isidro B. Salusky
Edward Lee
Christine Wang
Edward Posvar
机构：
[1] Amgen Inc.,Early Development
[2] Northwestern University,Feinberg School of Medicine, Children’s Memorial Hospital
[3] University of Alabama at Birmingham,Division of Pediatric Nephrology
[4] University of Missouri–Kansas City School of Medicine,Children’s Mercy Hospitals and Clinics
[5] David Geffen School of Medicine at UCLA,Division of Pediatric Nephrology, Department of Pediatrics
[6] Amgen Inc.,Metabolic Disorders
来源：
Pediatric Nephrology | 2012年 / 27卷
关键词：
Hyperparathyroidism; CKD–MBD; Hemodialysis; End-stage renal disease; Pharmacokinetics; Pharmacodynamics; Secondary;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1953 / 1959
页数：6
相关论文
共 50 条
  • [1] An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects
    Padhi, Desmond
    Langman, Craig B.
    Fathallah-Shaykh, Sahar
    Warady, Bradley A.
    Salusky, Isidro B.
    Lee, Edward
    Wang, Christine
    Posvar, Edward
    PEDIATRIC NEPHROLOGY, 2012, 27 (10) : 1953 - 1959
  • [2] An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis
    Winnie Y. Sohn
    Anthony A. Portale
    Isidro B. Salusky
    Hao Zhang
    Lucy L. Yan
    Bella Ertik
    Shahnaz Shahinfar
    Edward Lee
    Bastian Dehmel
    Bradley A. Warady
    Pediatric Nephrology, 2019, 34 : 145 - 154
  • [3] Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis
    Winnie Y. Sohn
    Anthony A. Portale
    Isidro B. Salusky
    Hao Zhang
    Lucy L. Yan
    Bella Ertik
    Shahnaz Shahinfar
    Edward Lee
    Bastian Dehmel
    Bradley A. Warady
    Pediatric Nephrology, 2019, 34 : 739 - 740
  • [4] An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28days to &lt;6years with chronic kidney disease receiving dialysis
    Sohn, Winnie Y.
    Portale, Anthony A.
    Salusky, Isidro B.
    Zhang, Hao
    Yan, Lucy L.
    Ertik, Bella
    Shahinfar, Shahnaz
    Lee, Edward
    Dehmel, Bastian
    Warady, Bradley A.
    PEDIATRIC NEPHROLOGY, 2019, 34 (01) : 145 - 154
  • [5] An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment
    Nakamaru, Yoshinobu
    Kakubari, Masae
    Yoshida, Kaori
    Akimoto, Makoto
    Kondo, Kazuoki
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1699 - 1714
  • [6] An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants
    Boinpally, Ramesh
    McGeeney, Danielle
    Kaczynski, Edward
    Weissman, Darren
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1341 - 1348
  • [7] Phase 1, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib in adult subjects
    Gao, Ling
    Yamamiya, Ikuo
    Pinti, Mark
    Rondon, Juan Carlos
    Gareth, Thomas Marbury
    Tomlinson, Gareth
    Makris, Lukas
    Hangai, Nanae
    Wacheck, Volker
    CANCER RESEARCH, 2023, 83 (08)
  • [8] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [9] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Shauna Hutton
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 141 - 146
  • [10] An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28days to &lt;6years with chronic kidney disease receiving dialysis (vol 34, pg 145, 2018)
    Sohn, Winnie Y.
    Portale, Anthony A.
    Salusky, Isidro B.
    Zhang, Hao
    Yan, Lucy L.
    Ertik, Bella
    Shahinfar, Shahnaz
    Lee, Edward
    Dehmel, Bastian
    Warady, Bradley A.
    PEDIATRIC NEPHROLOGY, 2019, 34 (04) : 739 - 740
12345